The calprotectin testing market has gained significant attention in recent years, owing to the rising awareness of gastrointestinal diseases and the importance of non-invasive diagnostic methods.

Interleukin-23 (IL-23) and its receptor are implicated in disease progression. IBD is associated with intestinal inflammation-mediated recruitment of neutrophils. Several neutrophil-associated ...

(100%) in the 180mg cohort achieved a clinical response Tryptase levels below the lower limit of quantification observed in ...

Beam reports breakthrough results from BEAM-101's early-stage trial for severe sickle cell disease. Read more here.

Studies doing genome-wide testing can easily ID patients with naturally low neutrophil counts, but nobody's looking at it, ...

Indian American immunologist selected as next Chair of University of Rochester Medical Center Department of Microbiology and Immunology ...

During a live event, John S. Renshaw, MD, and other oncologists discussed various trials of novel regimens for patients with chronic lymphocytic leukemia.

Scientists have discovered that certain immune cells—called neutrophils—can start making a protein called DUOX2 that they ...

Scientists have discovered that certain immune cells — called neutrophils — can start making a protein called DUOX2 that they ...

Study met primary endpoint of safety and tolerability at all doses and secondary pharmacodynamic and pharmacokinetic ...

New research reveals a surprising twist: how cells meant to protect us may be making things worse in gut diseases like ...

The drug Mavorixafor was previously granted the Fast Track designation for the treatment of WHIM syndrome, a rare immunodeficiency indication for which it received FDA approval in April 2024, X4 said.